Pseudomembranous Colitis

• EMA approval · 2025-12-01
  EMA Authorised: Zinplava (Bezlotoxumab) — Merck Sharp & Dohme B.V.

  EMA authorised Zinplava (bezlotoxumab) for enterocolitis, pseudomembranous colitis. Merck Sharp & Dohme B.V. is the marketing authorization …

• FDA approval · 2021-01-29
  FDA Approved: VANCOMYCIN HYDROCHLORIDE FOR ORAL SOLUTION — Supplemental Application (Wilshire Pharmaceuticals, Inc.)

  FDA approved a supplemental application to approve vancomycin hydrochloride for oral solution, expanding its use for treating Clostridioides…

• FDA approval · 2018-01-26
  FDA Approved: VANCOMYCIN HYDROCHLORIDE FOR ORAL SOLUTION — Original Application (Wilshire Pharmaceuticals, Inc.)

  The FDA approved Wilshire Pharmaceuticals' vancomycin hydrochloride for oral solution under an original NDA for the treatment of Clostridioi…